2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>
2019 · European Heart Journal · 8,581 citations
https://doi.org/10.1093/eurheartj/ehz455
М
М. В. Ежов
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
383
Papers
20.3K
Citations
35
h-index
78
i10-index
М. В. Ежов is an academic researcher from Institute of Electronic Measurements KVARZ (Russia). The author has contributed to research in topics: Lipoproteins and Cardiovascular Health & Cancer, Lipids, and Metabolism & Atherosclerosis and Cardiovascular Diseases. The author has an h-index of 35, co-authored 326 publications.
ORCID: 0000-0002-1518-6552Papers by this author
works2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
2019 · Atherosclerosis · 4,829 citations
https://doi.org/10.1016/j.atherosclerosis.2019.08.014
Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk
2019 · Circulation · 895 citations
https://doi.org/10.1161/circulationaha.118.037184
Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk
2020 · Circulation · 435 citations
https://doi.org/10.1161/circulationaha.120.046361
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
2021 · The Lancet · 288 citations
https://doi.org/10.1016/s0140-6736(21)01122-3
Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel
2017 · Nutrition Reviews · 278 citations
https://doi.org/10.1093/nutrit/nux047
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat